The AIM All Share dipped by 0.7% to 735.96 in the past five trading days, slightly underperforming the FTSE 100, which remained stagnant during that time.
The AIM All Share dipped by 0.7% to 735.96 in the past five trading days, slightly underperforming the FTSE 100, which remained stagnant during that time.
Evgen Pharma PLC (AIM: EVG), renowned for its advancements in sulforaphane-based medicine, recently revamped its board structure.
Global Market Update: China’s economic slowdown is rippling through global equity markets. The FTSE AIM All-Share Index declined by 3% this week. Similarly, both the FTSE 100 and FTSE 350 fell over 3.6%, while
Evgen Pharma PLC (AIM: EVG) has revealed the conclusive data from its Phase 1b study, which evaluated the new enteric-coated tablet formulation of its primary drug, SFX-01.
Evgen Pharma PLC (AIM: EVG), a clinical-stage pharmaceutical development firm, has disclosed the termination of its patent and knowledge licence agreement with JuvLife Ltd, a subsidiary of Juvenescence Ltd.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, DAX 40, Dow, Bitcoin,
Overall, it was a decent week for London’s junior markets, with AIM100 up 0.39% to 4,034 though it lagged against the Footsie, which rose more than 0.8%.
Quetzal Capital (QTZ), which has conditionally agreed to acquire Tap Global Limited, a regulated, crypto-fiat exchange service provider, notes recent developments in cryptocurrency markets concerning FTX Group and questions around
First healthy volunteers dosed on schedule
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax, Dow, Bitcoin, Aston,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, ARC Minerals, Baron Oil,